Anti‐Ro52 seropositivity as a diagnostic pitfall in myositis‐specific/associated antibody panels after intravenous immunoglobulin: Direct evidence from product and paired patient sera
Rafaella do Amaral Barbosa, Samuel Katsuyuki Shinjo. Anti‐Ro52 seropositivity as a diagnostic pitfall in myositis‐specific/associated antibody panels after intravenous immunoglobulin: Direct evidence from product and paired patient sera. // Vox Sanguinis. – 2026. – DOI: 10.1111/vox.70420. – URL: https://onlinelibrary.wiley.com/doi/10.1111/vox.70420?af=R
Rafaella do Amaral Barbosa & Samuel Katsuyuki Shinjo (2026). Anti‐Ro52 seropositivity as a diagnostic pitfall in myositis‐specific/associated antibody panels after intravenous immunoglobulin: Direct evidence from product and paired patient sera. Vox Sanguinis. https://doi.org/10.1111/vox.70420
Rafaella do Amaral Barbosa and Samuel Katsuyuki Shinjo. “Anti‐Ro52 seropositivity as a diagnostic pitfall in myositis‐specific/associated antibody panels after intravenous immunoglobulin: Direct evidence from product and paired patient sera.” Vox Sanguinis, 2026. doi:10.1111/vox.70420.
@article{Barbosa2026,
title = {Anti‐Ro52 seropositivity as a diagnostic pitfall in myositis‐specific/associated antibody panels after intravenous immunoglobulin: Direct evidence from product and paired patient sera},
author = {Barbosa, Rafaella do Amaral and Shinjo, Samuel Katsuyuki},
journal = {Vox Sanguinis},
year = {2026},
doi = {10.1111/vox.70420},
url = {https://onlinelibrary.wiley.com/doi/10.1111/vox.70420?af=R}
}